Literature DB >> 22974822

Cytokine mucosal expression in ulcerative colitis, the relationship between cytokine release and disease activity.

Daniel S Pearl1, Krina Shah, Mark A Whittaker, Harriet Nitch-Smith, James F Brown, Janis K Shute, Timothy M Trebble.   

Abstract

BACKGROUND: Ulcerative colitis (UC) is an inflammatory bowel disease with conflicting evidence from studies on the roles of TNFα, IL-8, TGFβ and other cytokines and characterised by neutrophil infiltration and tissue destruction. AIM: To compare cytokine profiles of inflamed and non-inflamed mucosa in patients with distal UC, and matched controls.
METHODS: Patients were prospectively recruited, mucosal biopsies at flexible sigmoidoscopy (FS) were taken from UC patients within macroscopically inflamed and non-inflamed proximal mucosa, and from age-sex matched controls undergoing FS. Endoscopic and histological inflammation was graded. Quantitative cytokine analysis for IL-4, TNFα, IL-17A, IL-8, IL-10, TGFβ and IFNγ was carried out on tissue homogenates. Statistical comparison was by Wilcoxon signed rank pair analysis, Mann-Whitney U test and Spearman's correlation.
RESULTS: 69 active UC patients (54 paired non-inflamed/inflamed mucosa) and 69 controls were compared. In inflamed mucosa, elevation in IL-8 and reduction in TGFβ was measured compared with non-inflamed mucosa (p<0.001; p<0.02) and control mucosa (p<0.001; p<0.001); IL-8 was positively correlated (rs=0.481, p<0.01) and TGFβ inversely correlated (rs=0.462; p<0.01) with grade of inflammation. TNFα concentration was not significantly different. Comparisons of inflamed with non-inflamed mucosa also demonstrate significant reduction in concentration of IFNγ (p<0.001), IL-4 (p<0.005) and IL-17A (p<0.002).
CONCLUSION: Our findings suggest that IL-8 is elevated and TGFβ is reduced in distal colitis. Lower concentration of IFNγ, IL-4 and IL-17A were also noted. TNFα levels were unchanged. These findings suggest that the inflammatory response in UC may predominantly involve IL-8 mediated neutrophil infiltration and failure of TGFβ mediated tissue healing.
Copyright © 2012 European Crohn's and Colitis Organisation. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22974822     DOI: 10.1016/j.crohns.2012.07.022

Source DB:  PubMed          Journal:  J Crohns Colitis        ISSN: 1873-9946            Impact factor:   9.071


  11 in total

1.  Assessment of serum cytokines predicts clinical and endoscopic outcomes to vedolizumab in ulcerative colitis patients.

Authors:  Lorenzo Bertani; Laura Baglietto; Luca Antonioli; Matteo Fornai; Gherardo Tapete; Eleonora Albano; Linda Ceccarelli; Maria Gloria Mumolo; Carolina Pellegrini; Ersilia Lucenteforte; Nicola de Bortoli; Massimo Bellini; Santino Marchi; Corrado Blandizzi; Francesco Costa
Journal:  Br J Clin Pharmacol       Date:  2020-02-18       Impact factor: 4.335

Review 2.  Interleukin-17 SNPs and serum levels increase ulcerative colitis risk: a meta-analysis.

Authors:  Juan Li; Hao Tian; Hui-Jun Jiang; Bin Han
Journal:  World J Gastroenterol       Date:  2014-11-14       Impact factor: 5.742

3.  IL-8 and LYPD8 expression levels are associated with the inflammatory response in the colon of patients with ulcerative colitis.

Authors:  Tomoyuki Okada; Tsutomu Kanda; Naoki Ueda; Yuichiro Ikebuchi; Keiichi Hashiguchi; Kazuhiko Nakao; Hajime Isomoto
Journal:  Biomed Rep       Date:  2020-02-20

4.  Cannabinoid receptor 2 agonist promotes parameters implicated in mucosal healing in patients with inflammatory bowel disease.

Authors:  Shelly Tartakover Matalon; Yehuda Ringel; Fred Konikoff; Liat Drucker; Shaul Pery; Timna Naftali
Journal:  United European Gastroenterol J       Date:  2019-11-14       Impact factor: 4.623

5.  Hypothalamic paraventricular nucleus stimulation reduces intestinal injury in rats with ulcerative colitis.

Authors:  Quan-Jun Deng; Ding-Jing Deng; Jin Che; Hai-Rong Zhao; Jun-Jie Yu; Yong-Yu Lu
Journal:  World J Gastroenterol       Date:  2016-04-14       Impact factor: 5.742

6.  Helicobacter bilis gamma-glutamyltranspeptidase enhances inflammatory stress response via oxidative stress in colon epithelial cells.

Authors:  Sundus Javed; Raquel Mejías-Luque; Behnam Kalali; Christian Bolz; Markus Gerhard
Journal:  PLoS One       Date:  2013-08-23       Impact factor: 3.240

7.  Altered colonic mucosal Polyunsaturated Fatty Acid (PUFA) derived lipid mediators in ulcerative colitis: new insight into relationship with disease activity and pathophysiology.

Authors:  Mojgan Masoodi; Daniel S Pearl; Michael Eiden; Janis K Shute; James F Brown; Philip C Calder; Timothy M Trebble
Journal:  PLoS One       Date:  2013-10-18       Impact factor: 3.240

8.  Novel Odoribacter splanchnicus Strain and Its Outer Membrane Vesicles Exert Immunoregulatory Effects in vitro.

Authors:  Kaisa Hiippala; Gonçalo Barreto; Claudia Burrello; Angelica Diaz-Basabe; Maiju Suutarinen; Veera Kainulainen; Jolene R Bowers; Darrin Lemmer; David M Engelthaler; Kari K Eklund; Federica Facciotti; Reetta Satokari
Journal:  Front Microbiol       Date:  2020-11-12       Impact factor: 5.640

9.  The Possible Anti-Inflammatory Effect of Dehydrocostus Lactone on DSS-Induced Colitis in Mice.

Authors:  Qing Zhou; Wei-Xin Zhang; Zong-Qi He; Ben-Sheng Wu; Zhao-Feng Shen; Hong-Tao Shang; Tuo Chen; Qiong Wang; Yu-Gen Chen; Shu-Tang Han
Journal:  Evid Based Complement Alternat Med       Date:  2020-01-30       Impact factor: 2.629

10.  Serum Interleukin-6 and -8 as Predictors of Response to Vedolizumab in Inflammatory Bowel Diseases.

Authors:  Lorenzo Bertani; Gian Paolo Caviglia; Luca Antonioli; Rinaldo Pellicano; Sharmila Fagoonee; Marco Astegiano; Giorgio Maria Saracco; Elisabetta Bugianesi; Corrado Blandizzi; Francesco Costa; Davide Giuseppe Ribaldone
Journal:  J Clin Med       Date:  2020-05-02       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.